Depression Clinical Trials in New York

Showing 221-240 of 322 trials

Minocycline for Bipolar Depression

NCT01514422

The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, and includes five outpatient visits.

Bipolar Depression

Icahn School of Medicine at Mount Sinai20 participantsStarted May 2011

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

NCT00005850

This trial is designed to test the efficacy of fluoxetine to improve patient's quality of life during chemotherapy. An innovative application of a selective serotonin reuptake inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of life.

Anxiety DisorderDepressionFatigue+1 more

Alliance for Clinical Trials in Oncology21 participantsStarted Aug 2001

Anniston, Alabama, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +40 more locations

Minocycline for Bipolar Depression

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Depression Trials in Other Cities

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Major Depressive Disorder With Mixed Features - Extension

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior

Treatment for Depression Among HIV-Infected Youth

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Early Detection and Intervention for the Prevention of Psychosis

Psychotherapy for Late Life Depression

Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors

Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease

Treatment of Depression in Parkinson's Disease Trial

Pilot BA Study of New LY03005 vs Pristiq

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

Other Conditions in New York